Neuehealth, INC 8-K filings

NeueHealth, Inc. has completed its take-private merger with an affiliate of New Enterprise Associates, with common stockholders receiving $7.33 per share in cash.

NeueHealth, Inc. announced an extension of the 'Outside Date' for its merger agreement with NH Holdings 2025, Inc. to December 23, 2025.

NeueHealth, Inc. announced strong second quarter 2025 financial results, driven by a significant increase in consumers served and continued Adjusted EBITDA profitability.

NeueHealth, Inc. announced the successful re-election of all ten director nominees and the ratification of Deloitte & Touche LLP as its independent auditor at its annual meeting of stockholders held on May 29, 2025.

NeueHealth, Inc. stockholders approved the merger agreement with NH Holdings 2025, Inc., paving the way for the company to become a private entity.

NeueHealth announces positive Adjusted EBITDA for the fifth consecutive quarter and a 51% increase in consumers served compared to Q1 2024, highlighting the success of its value-driven care model.

NeueHealth announces its Q4 and full-year 2024 financial results, highlighting its strongest financial performance to date and significant growth in consumers served.

NeueHealth's insurance subsidiaries have modified their repayment agreements with CMS regarding risk adjustment obligations, while the company is also in the process of being acquired by NH Holdings 2025, Inc.

NeueHealth, Inc. has agreed to be acquired by an affiliate of New Enterprise Associates (NEA) for approximately $1.3 billion, taking the company private.

NeueHealth delivered its strongest financial performance to date in Q3 2024, achieving positive Adjusted EBITDA for the third consecutive quarter and reaffirming its full-year guidance.

NeueHealth has acquired the remaining 25% equity interest in Centrum Health, making it a wholly-owned subsidiary, for a total consideration of $101.75 million.

NeueHealth announced its second quarter 2024 financial results, highlighting positive adjusted EBITDA for the second consecutive quarter and reaffirming its full-year guidance.

NeueHealth has secured a loan facility of up to $150 million with Hercules Capital to support its strategic priorities and strengthen its capital position.

NeueHealth, Inc. received a notice from the New York Stock Exchange for not meeting continued listing standards due to a low average market capitalization and stockholders' equity.

NeueHealth, Inc. held its 2024 Annual Meeting of Stockholders, where shareholders approved an amended incentive plan and elected ten directors.

NeueHealth's first quarter of 2024 saw a decrease in revenue compared to the previous year, but the company achieved net income and positive adjusted EBITDA.

NeueHealth has amended its credit facility with New Enterprise Associates, increasing its term loan commitment by $30 million and issuing warrants to purchase common stock.

NeueHealth reported a 55% year-over-year revenue increase to $1.2 billion in 2023, driven by its care delivery and provider enablement business, while serving 461,000 consumers.

Bright Health Group, Inc. has officially changed its corporate name to NeueHealth, Inc., with its common stock set to trade under the new ticker symbol 'NEUE' on the New York Stock Exchange starting January 29, 2024.